脉动给药系统的技术方面、挑战和应用综述

IF 3
Acharya Balkrishna, Shalini Mishra, Shalini Singh, Maneesha Rana, Ashwani Kumar, Satyendra Kumar Rajput, Tarun Kumar, Rahul Singh, Vedpriya Arya
{"title":"脉动给药系统的技术方面、挑战和应用综述","authors":"Acharya Balkrishna, Shalini Mishra, Shalini Singh, Maneesha Rana, Ashwani Kumar, Satyendra Kumar Rajput, Tarun Kumar, Rahul Singh, Vedpriya Arya","doi":"10.2174/0115672018351787250226045656","DOIUrl":null,"url":null,"abstract":"<p><p>The medicine is constantly released via a sustained and regulated drug delivery system per unit. However, there are several situations where it is undesirable to keep a drug's blood level constant. In these circumstances, pulsatile drug delivery could be preferable. Pulsatile drug delivery systems (PDDS) are gaining popularity because they deliver the medicine to the correct site of action at the proper time and in the right amount, offering spatial and temporal delivery and boosting patient compliance. These are essentially time-controlled drug delivery systems in which the system manages the lag time independent of environmental parameters such as pH, enzymes, gastrointestinal motility, etc. PDDS can be divided into three categories: time-controlled systems, where the delivery system controls drug release primarily; stimuli-induced systems, where release is programmed by external stimuli like magnetism, ultrasound, electrical effect, and irradiation; and externally regulated systems, where external stimuli like the pH or enzymes present in the intestinal tract or enzymes present in the drug delivery system control release. This article discusses several systems, such as capsular, osmotic, single- and multiple-unit systems based on soluble or erodible polymer covering and rupturable membranes. It summarizes the most recent technical innovations, formulation parameters, and system release profiles. This study also includes products available as once-daily formulations based on pulsatile releases, such as Pulsincap®, OROS®, CODAS®, and Pulsys®. These systems are helpful for medications with chronopharmacological behavior that need night-time dosage, pharmaceuticals with a first-pass solid action, and a particular location of absorption in the GIT. Diseases wherein PDDS are promising include asthma, peptic ulcer, cardiovascular ailments, arthritis, attention deficit syndrome in children, and hypercholesterolemia. PDDS can potentially bring new developments in the therapy of many diseases.</p>","PeriodicalId":94287,"journal":{"name":"Current drug delivery","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Technological Aspects, Challenges and Applications of Pulsatile Drug Delivery System-A Critical Review.\",\"authors\":\"Acharya Balkrishna, Shalini Mishra, Shalini Singh, Maneesha Rana, Ashwani Kumar, Satyendra Kumar Rajput, Tarun Kumar, Rahul Singh, Vedpriya Arya\",\"doi\":\"10.2174/0115672018351787250226045656\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The medicine is constantly released via a sustained and regulated drug delivery system per unit. However, there are several situations where it is undesirable to keep a drug's blood level constant. In these circumstances, pulsatile drug delivery could be preferable. Pulsatile drug delivery systems (PDDS) are gaining popularity because they deliver the medicine to the correct site of action at the proper time and in the right amount, offering spatial and temporal delivery and boosting patient compliance. These are essentially time-controlled drug delivery systems in which the system manages the lag time independent of environmental parameters such as pH, enzymes, gastrointestinal motility, etc. PDDS can be divided into three categories: time-controlled systems, where the delivery system controls drug release primarily; stimuli-induced systems, where release is programmed by external stimuli like magnetism, ultrasound, electrical effect, and irradiation; and externally regulated systems, where external stimuli like the pH or enzymes present in the intestinal tract or enzymes present in the drug delivery system control release. This article discusses several systems, such as capsular, osmotic, single- and multiple-unit systems based on soluble or erodible polymer covering and rupturable membranes. It summarizes the most recent technical innovations, formulation parameters, and system release profiles. This study also includes products available as once-daily formulations based on pulsatile releases, such as Pulsincap®, OROS®, CODAS®, and Pulsys®. These systems are helpful for medications with chronopharmacological behavior that need night-time dosage, pharmaceuticals with a first-pass solid action, and a particular location of absorption in the GIT. Diseases wherein PDDS are promising include asthma, peptic ulcer, cardiovascular ailments, arthritis, attention deficit syndrome in children, and hypercholesterolemia. PDDS can potentially bring new developments in the therapy of many diseases.</p>\",\"PeriodicalId\":94287,\"journal\":{\"name\":\"Current drug delivery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current drug delivery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115672018351787250226045656\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115672018351787250226045656","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

药物通过持续和受调节的药物输送系统不断释放。然而,在某些情况下,保持药物的血药浓度不变是不可取的。在这种情况下,搏动给药可能更可取。脉动给药系统(PDDS)越来越受欢迎,因为它们在适当的时间以适当的剂量将药物递送到正确的作用部位,提供空间和时间递送并提高患者的依从性。这些本质上是时间控制的药物输送系统,其中系统管理滞后时间独立于环境参数,如pH,酶,胃肠运动等。PDDS可分为三类:时间控制系统,其中递送系统主要控制药物释放;刺激诱导系统,通过外部刺激如磁力、超声波、电效应和辐照等来编程释放;以及外部调节系统,其中外部刺激如肠道中的pH值或酶或药物传递系统中的酶控制释放。本文讨论了几种基于可溶或可腐蚀聚合物覆盖和可破裂膜的系统,如胶囊式、渗透式、单单元和多单元系统。它总结了最新的技术革新、配方参数和系统发布概况。该研究还包括基于脉冲释放的每日一次配方的产品,如Pulsincap®,OROS®,CODAS®和Pulsys®。这些系统对需要夜间给药的具有时间药理学行为的药物、具有首过固体作用的药物和GIT中特定吸收位置的药物有帮助。PDDS有希望的疾病包括哮喘、消化性溃疡、心血管疾病、关节炎、儿童注意力缺陷综合征和高胆固醇血症。PDDS有可能为许多疾病的治疗带来新的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Technological Aspects, Challenges and Applications of Pulsatile Drug Delivery System-A Critical Review.

The medicine is constantly released via a sustained and regulated drug delivery system per unit. However, there are several situations where it is undesirable to keep a drug's blood level constant. In these circumstances, pulsatile drug delivery could be preferable. Pulsatile drug delivery systems (PDDS) are gaining popularity because they deliver the medicine to the correct site of action at the proper time and in the right amount, offering spatial and temporal delivery and boosting patient compliance. These are essentially time-controlled drug delivery systems in which the system manages the lag time independent of environmental parameters such as pH, enzymes, gastrointestinal motility, etc. PDDS can be divided into three categories: time-controlled systems, where the delivery system controls drug release primarily; stimuli-induced systems, where release is programmed by external stimuli like magnetism, ultrasound, electrical effect, and irradiation; and externally regulated systems, where external stimuli like the pH or enzymes present in the intestinal tract or enzymes present in the drug delivery system control release. This article discusses several systems, such as capsular, osmotic, single- and multiple-unit systems based on soluble or erodible polymer covering and rupturable membranes. It summarizes the most recent technical innovations, formulation parameters, and system release profiles. This study also includes products available as once-daily formulations based on pulsatile releases, such as Pulsincap®, OROS®, CODAS®, and Pulsys®. These systems are helpful for medications with chronopharmacological behavior that need night-time dosage, pharmaceuticals with a first-pass solid action, and a particular location of absorption in the GIT. Diseases wherein PDDS are promising include asthma, peptic ulcer, cardiovascular ailments, arthritis, attention deficit syndrome in children, and hypercholesterolemia. PDDS can potentially bring new developments in the therapy of many diseases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信